Abstract:Christian Kakisingi, 1 Michel Kabamba, 2 Michel Muteba, 3 Hermann Tamunbango, 4 Aristophane Tanon, 5 Hippolyte Situakibanza, 6 Claude Mwamba 1 1 Internal Medicine Department, University of Lubumbashi, Lubumbashi, Democratic Republic of the Congo; 2 Public Health Department, University of Kamina, Kamina, Democratic Republic of the Congo; 3 Division of Epidemiology and Biostatistics, University of Witwatersrand, Johannesburg, Republic of South Africa; 4 Epidemiology Department, Institut Supérieur de Techniques Médicales de Likasi, Likasi, Democratic Republic of the Congo; 5 Specialities and Medicine Department, University of Félix Houphouët-Boigny of Abidjan Cocody, Abidjan, Ivory Coast; 6 Internal Medicine Department, Tropical Diseases, Infectious and Parasitic Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo Correspondence: Christian Kakisingi, Email Background: Tuberculosis-Diabetes mellitus (TB-DM) co-morbidity is a growing scourge in the world. The new approaches and interventions for TB control implemented by the Tuberculosis National Control Program (TNCP) in DRC require the involvement of health care providers for their success. Objective: The objective of this study is to assess the knowledge of health care provider on different aspects of the management of TB-DM co-morbidity and to compare this knowledge according to the health care system, the type of providers and the number of years of experience. Methods: Cross-sectional and analytic study was conducted in 11 health care facilities in the Lubumbashi Health District, selected by reasoned choice, and an electronic questionnaire was administered to health care providers. These providers were interviewed on the different aspects of the management of the TB-DM comorbidity. The data were presented and compared in relation to knowledge about TB, DM, and TB-DM comorbidity. Results: A total of 113 providers were interviewed, predominantly males and physicians. Questions related to knowledge about DM were better answered. Doctors compared to paramedics; tertiary-level providers compared to secondary-level providers had better responses to the different questions. There is a statistically significant correlation between the level of knowledge of TB, DM and the type of health care provider, the number of years of experience. Conclusion: The present study shows that there are gaps in the knowledge of our health care providers and community members on the recommendations of the DRC TB guidelines ( Programme AntiTuberculeux Intégré 5 : PATI 5) in general and on the management of TB-DM. It is therefore important and necessary to put in place strategies to improve this level of knowledge, which will focus on the extension of the guidelines, the awareness and the training of the stakeholders involved in the control. Keywords: tuberculosis, diabetes mellitus, comorbidity, healthcare providers, knowledge Tuberculosis (TB) is a contagious, airborne disease. It is caused by a bacterium called Mycobacterium tuberculosis (M. tuberculosis) or Koch Bacillus (KB). Despite considerable progress over the years, TB is still a major public health problem worldwide. 1 In 2021, the number of new TB cases was estimated at 10.6 million, equivalent to 134 cases per 100,000 people. This scourge is listed as one of the top 10 causes of death worldwide, and to this day, millions of people continue to fall ill each year. 2 Worldwide, 30 countries are recognized as bearing the highest burden of this disease, collectively accounting for 85 to 89% of global prevalence. Among these 30 countries is the Democratic Republic of Congo (DRC), with an estimated incidence of 322 cases per 100,000 inhabitants in 2023 and an estimated mortality of 67 cases per 100,000 inhabitants. 3 Previous studies conducted by Kakisingi et al 4,5 in Haut-Katanga had shown the epidemiological impact in terms of morbidity and mortality of this disease in Lubumbashi in particular. In the DRC, the prevalence of DM reported by some authors varies between 3.5 and 14% and nearly 23000 deaths are attributable either to diabetes or hypoglycemia. Although there is a national program to combat DM in the DRC, very little data is reported to the national level; and, in view of the spread of scourge throughout the world, our country could not be spared from it as a result of the westernization of our lifestyle. 6–8 Historically, the association between TB and DM is well known and was already of concern to many clinicians and investigators at the beginning of the 20 th century. The influen -Abstract Truncated-

Comorbidity profiles among sputum-positive tuberculosis patients in Cameroon

Profile of non-tuberculous mycobacteria amongst tuberculosis presumptive people in Cameroon

Prevalence and Associated Factors of Diabetes Mellitus Among Newly Enrolled Tuberculosis Patients in Lubumbashi (DRC)

Prevalence, Epidemiological, and Clinical Profile of Patients Coinfected with Human Immunodeficiency Virus and Tuberculosis in the Coronavirus Disease 2019 Context in Health Facilities in the East Region, Cameroon

Prevalence of non-communicable diseases among household contacts of people with tuberculosis: A systematic review and individual participant data meta-analysis

Health Care Providers' Knowledge of Tuberculosis and Diabetes Mellitus Comorbidity in Lubumbashi, Democratic Republic of the Congo (DRC)

HIV, malnutrition, and noncommunicable disease epidemics among tuberculosis-affected households in east and southern Africa: A cross-sectional analysis of the ERASE-TB cohort

Comorbidity of mental ill-health in tuberculosis patients under treatment in a rural province of South Africa: a cross-sectional survey

The Double Burden of TB/HIV co-infection: Evidence from Central Region of Ghana.

Disability, comorbidities and risk determinants at end of TB treatment in Kenya, Uganda, Zambia and Zimbabwe

Mycobacterium tuberculosis and human immunodeficiency virus co-infection and associated variables among presumptive pulmonary tuberculosis patients in Ethiopia; a health institution based cross-sectional study

Tuberculosis patients with diabetes co-morbidity experience reduced Mycobacterium tuberculosis complex clearance

Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study

Human ace2 and tmprss2 polymorphisms for predicting susceptibility to tuberculosis and COVID-19 co-infection in Cameroonian cohort.

Cytokine and chemokine profiles in pulmonary tuberculosis with pre-diabetes

Tuberculosis-diabetes comorbidities: Mechanistic insights for clinical considerations and treatment challenges

Prevalence of Comorbid Tuberculosis Amongst COVID‐19 Patients: A Rapid Review and Meta‐analysis

Depression, anxiety and medication adherence among tuberculosis patients attending treatment centres in Fako Division, Cameroon: cross-sectional study

Tuberculosis and diabetes mellitus comorbidity in an adult Ugandan population

Managing Comorbidities, Determinants and Disability at Start and End of TB Treatment under Routine Program Conditions in China

Integration Challenges and Opportunity of Implementing Non-Communicable Disease Screening Intervention with Tuberculosis Patient Care: A Mixed Implementation Study